Literature DB >> 35066640

Differential impact of cold and hot tea extracts on tyrosine phosphatases regulating insulin receptor activity: a focus on PTP1B and LMW-PTP.

Massimo Genovese1, Simone Luti1, Elisa Pardella2, Mirella Vivoli-Vega1, Luigia Pazzagli1, Matteo Parri1, Anna Caselli1, Paolo Cirri1, Paolo Paoli1.   

Abstract

PURPOSE: The impact of tea constituents on the insulin-signaling pathway as well as their antidiabetic activity are still debated questions. Previous studies suggested that some tea components act as Protein Tyrosine Phosphatase 1B (PTP1B) inhibitors. However, their nature and mechanism of action remain to be clarified. This study aims to evaluate the effects of both tea extracts and some of their constituents on two main negative regulators of the insulin-signaling pathway, Low-Molecular-Weight Protein Tyrosine Phosphatase (LMW-PTP) and PTP1B.
METHODS: The effects of cold and hot tea extracts on the enzyme activity were evaluated through in vitro assays. Active components were identified using gas chromatography-mass spectrometry (GC-MS) analysis. Finally, the impact of both whole tea extracts and specific active tea components on the insulin-signaling pathway was evaluated in liver and muscle cells.
RESULTS: We found that both cold and hot tea extracts inhibit LMW-PTP and PTP1B, even if with a different mechanism of action. We identified galloyl moiety-bearing catechins as the tea components responsible for this inhibition. Specifically, kinetic and docking analyses revealed that epigallocatechin gallate (EGCG) is a mixed-type non-competitive inhibitor of PTP1B, showing an IC50 value in the nanomolar range. Finally, in vitro assays confirmed that EGCG acts as an insulin-sensitizing agent and that the chronic treatment of liver cells with tea extracts results in an enhancement of the insulin receptor levels and insulin sensitivity.
CONCLUSION: Altogether, our data suggest that tea components are able to regulate both protein levels and activation status of the insulin receptor by modulating the activity of PTP1B.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.

Entities:  

Keywords:  Epigallocatechin gallate; Insulin resistance; PTP1B inhibitors; Tea extracts; Type 2 diabetes

Mesh:

Substances:

Year:  2022        PMID: 35066640     DOI: 10.1007/s00394-021-02776-w

Source DB:  PubMed          Journal:  Eur J Nutr        ISSN: 1436-6207            Impact factor:   5.614


  40 in total

Review 1.  Antidiabetic Drugs: Mechanisms of Action and Potential Outcomes on Cellular Metabolism.

Authors:  Maria J Meneses; Branca M Silva; Mário Sousa; Rosália Sá; Pedro F Oliveira; Marco G Alves
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116

Review 2.  Natural anti-obesity agents and their therapeutic role in management of obesity: A future trend perspective.

Authors:  Sravani Karri; Sanjay Sharma; Ketan Hatware; Kiran Patil
Journal:  Biomed Pharmacother       Date:  2018-11-24       Impact factor: 6.529

Review 3.  PTP1b Inhibition, A Promising Approach for the Treatment of Diabetes Type II.

Authors:  Phaedra Eleftheriou; Athina Geronikaki; Anthi Petrou
Journal:  Curr Top Med Chem       Date:  2019       Impact factor: 3.295

4.  Tea contains potent inhibitors of tyrosine phosphatase PTP1B.

Authors:  Junfeng Ma; Zhe Li; Shu Xing; Wan-Ting Tina Ho; Xueqi Fu; Zhizhuang Joe Zhao
Journal:  Biochem Biophys Res Commun       Date:  2011-02-28       Impact factor: 3.575

Review 5.  Global aetiology and epidemiology of type 2 diabetes mellitus and its complications.

Authors:  Yan Zheng; Sylvia H Ley; Frank B Hu
Journal:  Nat Rev Endocrinol       Date:  2017-12-08       Impact factor: 43.330

Review 6.  Prevention and management of type 2 diabetes: dietary components and nutritional strategies.

Authors:  Sylvia H Ley; Osama Hamdy; Viswanathan Mohan; Frank B Hu
Journal:  Lancet       Date:  2014-06-07       Impact factor: 79.321

Review 7.  Treatment of type 2 diabetes: future approaches.

Authors:  Clifford J Bailey; Caroline Day
Journal:  Br Med Bull       Date:  2018-06-01       Impact factor: 4.291

8.  Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus.

Authors:  Ralph A Defronzo
Journal:  Diabetes       Date:  2009-04       Impact factor: 9.461

9.  Diabetes reversal by inhibition of the low-molecular-weight tyrosine phosphatase.

Authors:  Stephanie M Stanford; Alexander E Aleshin; Vida Zhang; Robert J Ardecky; Michael P Hedrick; Jiwen Zou; Santhi R Ganji; Matthew R Bliss; Fusayo Yamamoto; Andrey A Bobkov; Janna Kiselar; Yingge Liu; Gregory W Cadwell; Shilpi Khare; Jinghua Yu; Antonio Barquilla; Thomas D Y Chung; Tomas Mustelin; Simon Schenk; Laurie A Bankston; Robert C Liddington; Anthony B Pinkerton; Nunzio Bottini
Journal:  Nat Chem Biol       Date:  2017-03-27       Impact factor: 15.040

Review 10.  Risk factors contributing to type 2 diabetes and recent advances in the treatment and prevention.

Authors:  Yanling Wu; Yanping Ding; Yoshimasa Tanaka; Wen Zhang
Journal:  Int J Med Sci       Date:  2014-09-06       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.